Here are four things to know about the deal.
1. Capsugel, based in Morristown, N.J., manufactures empty drug capsules, along with several other drug delivery systems.
3. Lonza’s shares fell by more than 7 percent to 157 Swiss francs ($154) per share upon news of the acquisition, which cost the Swiss company more than 60 percent of its market value.
4. The deal is expected to close in the second quarter of 2017.
More articles on supply chain:
FDA approves Pfitzer’s eczema treatment
5 latest FDA approvals
7 supply chain lessons from auto and retail industries
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
